Format

Send to

Choose Destination
Qual Life Res. 2014 Jun;23(5):1427-34. doi: 10.1007/s11136-013-0593-4. Epub 2013 Dec 7.

Quality of life assessed with EQ-5D in patients undergoing glioma surgery: what is the responsiveness and minimal clinically important difference?

Author information

1
Department of Neuroscience, Norwegian University of Science and Technology, 7491, Trondheim, Norway, lisa.millgard.sagberg@ntnu.no.

Abstract

PURPOSE:

To evaluate the responsiveness of EQ-5D 3L in patients undergoing intracranial glioma surgery and estimate the minimal clinically important difference (MCID).

MATERIALS AND METHODS:

EQ-5D 3L index values from 164 patients who underwent glioma surgery in the period 2007-2012 were analysed. Responsiveness and MCID were estimated using a combination of distribution-based and anchor-based methods. Karnofsky performance status served as an anchor.

RESULTS:

Patients who improved functionally did not report significantly higher EQ-5D 3L scores post operatively with a standardized response mean (SRM) of 0.04 (p = 0.13). Patients who deteriorated functionally reported significantly lower EQ-5D 3L scores post operatively with a SRM of 0.72 (p < 0.001). With different approaches, we determined a range of MCID values from 0.13 to 0.15.

CONCLUSIONS:

EQ-5D 3L is responsive to changes when glioma patients are deteriorating functionally after surgery but not responsive when the patients are improving. The MCID values for EQ-5D 3L in glioma surgery seem higher than reported MCID values for other types of cancers.

PMID:
24318084
DOI:
10.1007/s11136-013-0593-4
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center